PTC Therapeutics, Inc.
PTCT
$75.25
-$0.92-1.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.90M | -64.85M | 866.56M | -65.89M | -106.65M |
| Total Depreciation and Amortization | 11.11M | 7.58M | 7.22M | 6.76M | 6.49M |
| Total Amortization of Deferred Charges | 305.00K | 302.00K | 299.00K | 307.00K | 300.00K |
| Total Other Non-Cash Items | -8.74M | 15.35M | 38.10M | -7.77M | 13.04M |
| Change in Net Operating Assets | -84.88M | -16.72M | -42.08M | 36.58M | 9.83M |
| Cash from Operations | -66.30M | -58.33M | 870.10M | -30.00M | -76.99M |
| Capital Expenditure | -3.45M | -1.32M | -1.72M | -3.77M | -522.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 70.00K | 0.00 | 18.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -286.18M | -420.69M | -182.71M | 271.48M | -42.17M |
| Cash from Investing | -289.62M | -422.01M | -184.36M | 267.71M | -42.68M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.61M | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 16.83M | 3.96M | 15.75M | 26.47M | 573.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -6.34M | 0.00 | -18.20M |
| Cash from Financing | 15.22M | 3.96M | 9.41M | 26.47M | -17.63M |
| Foreign Exchange rate Adjustments | -6.06M | 13.59M | 5.39M | -8.65M | 8.54M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -346.77M | -462.79M | 700.55M | 255.53M | -128.75M |